So far, the Golden Dome seems more like a marketing concept designed to enrich arms contractors and burnish Trump’s image ...
Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that ...
Annual Sales of $615.3 millionFourth quarter Sales of $150.7 million, Net Income of $8.2 million and EPS of $0.22 Fourth quarter EBITDA1 of $18.0 million, 11.9% of salesFree Cash Flow1 of $13.8 millio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback